| SenSen Networks Limited (SNS) ORDINARY FULLY PAID |
Information Technology |
$63 |
Appendix 4E
|
29 Aug 2025 10:34AM |
$0.026 |
$0.080 |
risen by
207.69%
|
|
SNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 26.5% to $15,359,069.
- Profit after tax switched to a profit of $449,972 from a loss.
- Earnings per share rose to 0.06 cents.
- No dividends declared for the financial period.
- SenSen's Live Awareness AI Platform enhances urban management.
- Financial report based on audited consolidated statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$15 |
Half Yearly Report and Accounts
|
29 Aug 2025 10:33AM |
$0.225 |
$0.270 |
risen by
20%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax for the half-year was $3,004,720.
- Total revenue for the period was $13,655,025.
- The software segment focuses on imaging systems for Radiology, Cardiology, and Pathology.
- Radiology Services are provided in Colombia and Spain.
- An impairment of goodwill negatively impacted financial results.
- Issued capital increased to $42,737,585.
- Foreign currency translation resulted in other comprehensive income.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$15 |
Half Yearly Report and Accounts
|
29 Aug 2025 10:33AM |
$0.225 |
$0.270 |
risen by
20%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after tax of $3,004,720 for the half-year ended 30 June 2025.
- Revenue primarily from leasing equipment and software services.
- Significant impairment charge of $1,748,845.
- Total revenue of $13,655,025, a slight decrease from the previous year.
- Majority of revenue from Latin America.
- EBITDA loss of $1.7 million, compared to break-even in the previous period.
- Raised $2.6 million through share issues and placements.
- Focus on radiology services using medical imaging software.
- Confidence in meeting liabilities as they fall due.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Spacetalk Ltd (SPA) ORDINARY FULLY PAID |
Information Technology |
$10 |
25% Growth in Recurring Revenues in a Transformative FY25
|
29 Aug 2025 10:33AM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
SPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Annual recurring revenue grew by 25% to $12.1 million.
- Paid mobile subscribers increased by 44% to 44.4k.
- Revenue from continuing operations rose by 12% to $19.6 million.
- Gross profit margins improved to 50%.
- Operating expenses decreased by 11% to $12.5 million.
- Adjusted EBITDA improved by 57% to $(1.9) million.
- Debt restructuring with Pure Asset Management to support growth.
- Focus on expanding subscriptions and product offerings.
- Targeting $20–25 million ARR in 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Spacetalk Ltd (SPA) ORDINARY FULLY PAID |
Information Technology |
$10 |
25% Growth in Recurring Revenues in a Transformative FY25
|
29 Aug 2025 10:33AM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
SPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Spacetalk Ltd achieved a 25% increase in annual recurring revenue, reaching $12.1 million in FY25.
- Paid mobile subscribers grew by 44% year-on-year to 44.4k.
- Revenue from continuing operations increased by 12% to $19.6 million.
- The company's gross profit was $9.7 million, with a margin improvement to 50%.
- Operating expenses reduced by 11% to $12.5 million.
- Adjusted EBITDA improved by 57% to ($1.9 million), moving closer to profitability.
- The company ended the year with a cash balance of $1.1 million.
- Spacetalk restructured its debt facilities, converting $1 million of secured debt into Converting Notes.
- Pure Asset Management agreed to suspend all capital repayments for the remainder of 2025 and extend the loan maturity date to June 2027.
- The company plans to expand internationally using digital channels and develop new hardware and software products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Matsa Resources Limited (MAT) ORDINARY FULLY PAID |
Materials |
$93 |
Secondary Trading Notice
|
29 Aug 2025 10:32AM |
$0.076 |
$0.120 |
risen by
57.89%
|
|
| Dotz Nano Limited (DTZ) ORDINARY FULLY PAID |
Information Technology |
$37 |
Pause in Trading
|
29 Aug 2025 10:32AM |
$0.055 |
$0.060 |
risen by
9.09%
|
|
DTZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading in Dotz Nano Limited securities was paused.
- Security Code for Dotz Nano Limited is DTZ.
- The pause in trading is pending a further announcement.
- Announcement made by ASX Listings Compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dotz Nano Limited (DTZ) ORDINARY FULLY PAID |
Information Technology |
$37 |
Pause in Trading
|
29 Aug 2025 10:32AM |
$0.055 |
$0.060 |
risen by
9.09%
|
|
DTZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Dotz Nano Limited trading paused.
- Security code DTZ affected.
- Pause pending further announcement.
- Managed by ASX Listings Compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peninsula Energy Limited (PEN) ORDINARY FULLY PAID |
Energy |
$81 |
Letter to Eligible Shareholders
|
29 Aug 2025 10:31AM |
$0.363 |
$0.295 |
fallen by
18.62%
|
|
| Peninsula Energy Limited (PEN) ORDINARY FULLY PAID |
Energy |
$81 |
Letter to Ineligible Shareholders
|
29 Aug 2025 10:30AM |
$0.363 |
$0.295 |
fallen by
18.62%
|
|
| Spacetalk Ltd (SPA) ORDINARY FULLY PAID |
Information Technology |
$10 |
Appendix 4E and FY25 Financial Statements
|
29 Aug 2025 10:29AM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
SPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for FY25 was $19.6 million.
- Net loss was reported with significant costs in sales, depreciation, and share-based payments.
- Share consolidation and issuance of options and performance rights linked to milestones.
- Revised loan facility with Pure Asset Management with a suspension of repayments for 2025.
- Total assets were $8.6 million and liabilities were $12.9 million, leading to net liabilities of $4.3 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Matsa Resources Limited (MAT) ORDINARY FULLY PAID |
Materials |
$93 |
Application for quotation of securities - MAT
|
29 Aug 2025 10:29AM |
$0.076 |
$0.120 |
risen by
57.89%
|
|
| Spacetalk Ltd (SPA) ORDINARY FULLY PAID |
Information Technology |
$10 |
Appendix 4E and FY25 Financial Statements
|
29 Aug 2025 10:29AM |
$0.130 |
$0.140 |
risen by
7.69%
|
|
SPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Spacetalk Ltd's total revenue for FY25 was $19.6 million.
- Net loss after tax reduced to $4.5 million for FY25.
- Effective cost management and restructuring reduced operating expenses to $12.5 million.
- Share-based compensation and equity transactions affected financial outcomes.
- Improvements in cash flow due to operational efficiencies and cost savings.
- Capital raises and debt management with Pure Asset Management were key financial strategies.
- Shareholder equity increased through new share issuance and consolidation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WEB Travel Group Limited (WEB) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,492 |
Appendix 3Y - Denise McComish
|
29 Aug 2025 10:29AM |
$4.490 |
$4.130 |
fallen by
8.02%
|
|
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$737 |
Appendix 4G and 2025 Corporate Governance Statement
|
29 Aug 2025 10:28AM |
$3.440 |
$3.300 |
fallen by
4.07%
|
|
| Codan Limited (CDA) ORDINARY FULLY PAID |
Information Technology |
$5,629 |
Notification of cessation of securities - CDA
|
29 Aug 2025 10:28AM |
$29.860 |
$30.950 |
risen by
3.65%
|
|
| Phoslock Environmental Technologies Limited (PET) ORDINARY FULLY PAID |
Industrials |
$4 |
Appendix 4D and Half Year report 30 June 2025
|
29 Aug 2025 10:28AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
PET - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 147.8% to $1,425,000.
- Net loss after tax rose by 79.8% to $1,057,000.
- Comprehensive loss for the half-year was $1,021,000.
- Total equity decreased to $8,986,000 as of June 2025.
- No dividends were declared during the period.
- Legal proceedings are ongoing, with no reliable estimate of potential financial impact.
- Inventory management includes addressing quality issues in Phoslock® products.
- Cash reserves expected to last for at least eight quarters.
- Segment revenue from US/Canada/Brazil led with $955,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Phoslock Environmental Technologies Limited (PET) ORDINARY FULLY PAID |
Industrials |
$4 |
Appendix 4D and Half Year report 30 June 2025
|
29 Aug 2025 10:28AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
PET - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax was $1.057 million.
- Revenue increased by 148% to $1.425 million.
- Strong sales in Brazil contributed significantly to revenue.
- No dividends were declared for the period.
- Net assets were $8.986 million as of 30 June 2025.
- The company is focused on global expansion and market diversification.
- Ongoing investigations by the Australian Federal Police and ASIC.
- Cash reserves are expected to support operations for at least the next eight quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mirrabooka Investments Limited (MIR) ORDINARY FULLY PAID |
Financials |
$737 |
2025 Annual Reports and AGM Documentation
|
29 Aug 2025 10:27AM |
$3.440 |
$3.300 |
fallen by
4.07%
|
|
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$16 |
FY25 Full Year Results & FY26 Guidance Investor Presentation
|
29 Aug 2025 10:27AM |
$0.041 |
$0.034 |
fallen by
17.07%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue increased by 29% to $11.1M.
- Compounded annual growth rate from FY23 to FY25 was 43%.
- Normalized operating EBITDA of $1.4M, up 24% from FY24.
- $13.8M clinical trial progressing as planned.
- SaMD service agreements worth ~$4.5M in new contracts.
- Cost efficiency program expected to save $1.1M annually.
- FY26 revenue guidance is $17M with $2M EBITDA target.
- Continued growth expected in SaMD, CRO services, and TrialsWest.
- Exploration of new contract opportunities and expansions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$16 |
FY25 Full Year Results & FY26 Guidance Investor Presentation
|
29 Aug 2025 10:27AM |
$0.041 |
$0.034 |
fallen by
17.07%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue grew 29% to $11.1 million.
- Normalized operating EBITDA increased 24% to $1.4 million.
- Record cash receipts from customers totaled $14 million.
- Major clinical trial contracts secured, including a $13.8 million trial.
- Cost efficiency program completed with $1.1 million projected savings.
- FY26 revenue guidance of $17 million and EBITDA of $2 million.
- Continued expansion in SaMD and clinical trial services.
- Focus on automation to increase business capacity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$16 |
Appendix 4E & Full Year Statutory Accounts
|
29 Aug 2025 10:27AM |
$0.041 |
$0.034 |
fallen by
17.07%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after tax of AUD 1.73 million for FY 2025.
- Revenue increased to AUD 11.07 million, driven by EMEA sales.
- Net assets decreased from AUD 10.93 million in 2024 to AUD 9.39 million in 2025.
- Investment in MRI-based diagnostic tools and refining existing products.
- Acquisition of TrialsWest impacting cash flows and financial position.
- Significant investments in property, plant, equipment, and intangible assets.
- Amortization and depreciation impacted financial results.
- Company remains focused on leveraging diagnostic innovations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$16 |
Appendix 4E & Full Year Statutory Accounts
|
29 Aug 2025 10:27AM |
$0.041 |
$0.034 |
fallen by
17.07%
|
|
RHT - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax of $1,732,939 for the year ended 30 June 2025.
- Revenue increased to $11,073,018.
- Basic and diluted loss per share at (0.38) cents.
- Net assets valued at $9,390,797.
- Total liabilities amounted to $8,498,850.
- Investments in TrialsWest acquisition.
- New trial site announced in Mandurah, Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Codan Limited (CDA) ORDINARY FULLY PAID |
Information Technology |
$5,629 |
Application for quotation of securities - CDA
|
29 Aug 2025 10:25AM |
$29.860 |
$30.950 |
risen by
3.65%
|
|
| Story-I Limited (SRY) ORDINARY FULLY PAID |
Consumer Discretionary |
$2 |
Removal from Official List - Annual Listing Fees
|
29 Aug 2025 10:25AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
Call 1300 880 160
Start a chat
Schedule a call
